Expression and synthesis of TGFβ1 is induced in macrophages by 9-oxononanoyl cholesterol, a major cholesteryl ester oxidation product

BioFactors

Volumn 24, Issue 1-4, 2005, Pages 209-216

  Sottero, Barbara ^a   Gamba, Paola ^a   Longhi, Monica ^a   Robbesyn, Fanny ^a   Abuja, Peter M ^b   Schaur, Rudolf J ^b   Poli, Giuseppe ^a   Leonarduzzi, Gabriella ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

9 oxononanoyl cholesterol; Core aldehyde; Fibrogenesis; Macrophages; TGF 1

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE; BIOMATERIAL; CHOLESTEROL DERIVATIVE; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN; OXYSTEROL; TRANSFORMING GROWTH FACTOR BETA1; 9 OXONONANOYL CHOLESTEROL; 9-OXONONANOYL CHOLESTEROL; CHOLESTEROL; CHONDROCYTE GROWTH FACTORS; DRUG DERIVATIVE; MESSENGER RNA; PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESTERIFICATION; FIBROGENESIS; LIPID OXIDATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CELL LINE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETICS; METABOLISM; NORTHERN BLOTTING; WESTERN BLOTTING;

ANIMALIA;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CHOLESTEROL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; MACROPHAGES; MICE; PROTEINS; RNA, MESSENGER;

EID: 28644439562     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520240125     Document Type: Article

References (36)

1. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo and J.L. Witztum, Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity, N. Engl. J. Med. 320 (1989), 915-924.
2. R. Ross, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature 362 (1993), 801-809.
3. H. Esterbauer and P. Ramos, Chemistry and pathophysiology of oxidation of LDL, Rev. Physiol. Biochem. Pharmacol. 127 (1996), 31-64.
4. S.L. Hazen, J.P. Gaut, J.R. Crowley, F.F. Hsu and J.W. Heinecke, Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions, Biochem. J. 352 (2000), 693-699.
5. A.J. Brown and W. Jessup, Oxysterols and atherosclerosis, Atherosclerosis 142 (1999), 1-28.
6. G.J. Schroepfer, Oxysterols: modulators of cholesterol metabolism and other processes, Physiol. Rev. 80 (2000), 361-554.
7. G. Leonarduzzi, A. Sevanian, B. Sottero, M.C. Arkan, F. Biasi, E. Chiarpotto, H. Basaga and G. Poli, Up-regulation of the fibrogenic cytokine TGF-β1 by oxysterols: a mechanistic link between cholesterol and atherosclerosis, FASEB J 15 (2001), 1619-1621.
8. M.M. Shull, I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata and T. Doetschman, Targeted disruption of the mouse transforming growth factor-beta1 gene results in multifocal inflammatory disease, Nature 359 (1992), 693-699.
9. W.A. Border and N.A. Noble, Transforming growth factor β in tissue fibrosis, New Engl. J. Med. 331 (1994), 1286-1292.
10. J.P. Grande, Role of transforming growth factor β in tissue injury and repair, Proc. Soc. Exp. Biol. Med. 214 (1997), 27-40.
11. J. Massagué, TGF-β signal transduction, Annu. Rev. Biochem. 67 (1998), 753-791.
12. N.A. Porter, S.E. Caldwell and K.A. Mills, Mechanisms of free radical oxidation of unsaturated lipids, Lipids 30 (1995), 277-290.
13. H. Esterbauer, G. Jürgens, O. Quehenberger and E. Koller, Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes, J. Lipid Res. 28 (1987), 495-509.
14. H. Esterbauer, R.J. Schaur and H. Zollner, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Rad. Biol. Med. 11 (1991), 81-128.
15. H. Kamido, A. Kuksis, L. Marai and J.J. Myher, Identification of cholesterol-bound aldehydes in copper-oxidized low density lipoprotein, FEBS Lett. 304 (1992), 269-272.
16. H. Kamido, A. Kuksis, L. Marai and J.J. Myher, Identification of core aldehydes among in vitro peroxidation products of cholesteryl esters, Lipids 28 (1993), 331-336.
17. H. Kamido, A. Kuksis, E. Marai and J.J. Myher, Lipid ester-bound aldehydes among copper-catalyzed peroxidation products of human plasma lipoproteins, J. Lipid Res. 36 (1995), 1876-1886.
18. M. Parola, G. Robino and M.U. Dianzani, 4-Hydroxy-2,3-alkenals as molecular mediators of oxidative stress in the pathogenesis of liver fibrosis, Int. J. Mol. Med. 4 (1999), 425-432.
19. G. Poli and R.J. Schaur, 4-Hydroxynonenal in the pathomechanism of oxidative stress, IUBMB Life 50 (2000), 315-321.
20. G. Leonarduzzi, A. Scavazza, F. Biasi, E. Chiarpotto, S. Camandola, S. Vogl, R. Dargel and G. Poli, The lipid peroxidation end-product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis, FASEB J. 11 (1997), 851-857.
21. G. Leonarduzzi, M.C. Arkan, H. Basaga, E. Chiarpotto, A. Sevanian and G. Poli, Lipid oxidation products in cell signalling, Free Rad. Biol. Med. 28 (2000), 1370-1378.
22. C. Napoli, F.P. D'Armiento, F.P. Mancini, A. Postiglione, J.L. Witztum, G. Palumbo and W. Palinski, Fatty steak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions, J. Clin. Invest. 100 (1997), 2680-2690.
23. A.D. Watson, M. Navab, S.Y. Hama, A. Sevanian, S.M. Prescott, D.M. Stafforini, T.M. McIntyre, B.N. La Du, A.M. Fogelman and J.A. Berliner, Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein, J. Clin. Invest. 95 (1995), 774-782.
24. N. Leitinger, A.D. Watson, S.Y. Hama, B. Ivandic, J.H. Qiao, J. Huber, K.F. Faull, D.S. Grass, M. Navab, A.M. Fogelman, F.C. de Beer, A.J. Lusis and J.A. Berliner, Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids, Arterioscler. Thromb. Vasc. Biol. 19 (1999), 1291-1298.
25. A.D. Watson, N. Leitinger, M. Navab, K.F. Faull, S. Horkko, J. Witztum, W. Palinski, D. Schwenke, R.G. Salomon, W. Sha, G. Subbanagounder, A.M. Fogelman and J.A. Berliner, Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo, J. Biol. Chem. 272 (1997), 13597-13607.
26. H. Itabe, E. Takeshima, H. Iwasaki, J. Kimura, Y. Yoshida, T. Imanaka and T. Takano, A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides, J. Biol. Chem. 269 (1994), 15274-15279.
27. A. Tokumura, A family of phospholipid autacoids: occurrence, metabolism and bioactions, Prog. Lipid Res. 34 (1995), 151-184.
28. T. Tanaka, M. Iimori, H. Tsukatani and A. Tokumura, Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group, Biochim. Biophys. Acta. 1210 (1994), 202-208.
29. P.L. Smiley, K.E. Stremler, S.M. Prescott, G.A. Zimmerman and T.M. McIntyre, Oxidatively fragmented phosphatidyl-cholines activate human neutrophils through the receptor for platelet-activating factor, J. Biol. Chem. 266 (1991), 11104-11110.
30. K.D. Patel, G.A. Zimmerman, S.M. Prescott and T.M. McIntyre, Novel leukocyte agonists are released by endothelial cells exposed to peroxide, J. Biol. Chem. 267 (1992), 15168-15175.
31. J. Huber, A. Vales, G. Mitulovic, M. Blumer, R. Schmid, J.L. Witztum, B.R. Binder and N. Leitinger, Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions, Arterioscler. Thromb. Vasc. Biol. 22 (2002), 101-107.
32. G. Hoppe, A. Ravandi, D. Herrera, A. Kuksis and H.F. Hoff, Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atheroschlerotic lesion, J. Lipid Res. 38 (1997), 1347-1360.
33. B. Karten, H. Boechzelt, P.M. Abuja, M. Mittelbach, K. Oettl and W. Sattler, Femtomole analisys of 9-oxononanoyl cholesterol by high performance liquid chromatography, J. Lipid Res. 39 (1998), 1508-1519.
34. B. Karten, H. Boechzelt, P.M. Abuja, M. Mittelbach and W. Sattler, Macrophage-enhanced formation of cholesteryl ester-core aldehydes during oxidation of low density lipoprotein, J. Lipid Res. 40 (1999), 1240-1253.
35. H. Boechzelt, B. Karten, P.M. Abuja, W. Slatter and M. Mittelbach, Synthesis of 9-oxononanoyl cholesterol by ozonization, Lipid Res. 39 (1998), 1503-1507.
36. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976), 248-254.